Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells

Nature Communications

Volumn 5, Issue , 2014, Pages

  Steinsbø, Øyvind ^a   Dunand, Carole J Henry ^b   Huang, Min ^b   Mesin, Luka ^a   Salgado Ferrer, Marlene ^b   Lundin, Knut E A ^a,c   Jahnsen, Jørgen ^d   Wilson, Patrick C ^b   Sollid, Ludvig M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF CHICAGO   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN; GLUTEN; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; TETRAMER; EPITOPE; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ANTIBODY; CELL ORGANELLE; DETECTION METHOD; DISEASE PREVALENCE; IMMUNE SYSTEM; MUTATION; PEPTIDE; PLASMA;

ARTICLE; B LYMPHOCYTE; CELIAC DISEASE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; PLASMA CELL; PROTEIN BINDING; SMALL INTESTINE; SOMATIC HYPERMUTATION; SOMATIC MUTATION; T LYMPHOCYTE; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; IMMUNOLOGY; MUTATION;

AMINO ACID SEQUENCE; CELIAC DISEASE; EPITOPES; GLIADIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; MUTATION; PLASMA CELLS;

EID: 84902253702     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5041     Document Type: Article

References (50)

1. Green, P. H. & Cellier, C. Celiac disease. New Engl. J. Med. 357, 1731-1743 (2007).
2. Sollid, L. M. Coeliac disease: dissecting a complex inflammatory disorder. Nat. Rev. Immunol. 2, 647-655 (2002). (Pubitemid 37328722)
3. Lundin, K. E. et al. Gliadin-specific, HLA-DQ(α10501,β10201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178, 187-196 (1993). (Pubitemid 23173254)
4. Lycke, N., Kilander, A., Nilsson, L. A., Tarkowski, A. & Werner, N. Production of antibodies to gliadin in intestinal mucosa of patients with coeliac disease: a study at the single cell level. Gut 30, 72-77 (1989). (Pubitemid 19038576)
5. Di Niro, R. et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat. Med. 18, 441-445 (2012).
6. Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H. & Murray, J. A. ACG clinical guidelines: diagnosis and management of celiac disease. Am. J. Gastroenterol. 108, 656-676 (2013).
7. Husby, S. et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr. 54, 136-160 (2012).
8. Anderson, R. P. et al. A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways. BMC Med. 11, 188 (2013).
9. Rostom, A. et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128, S38-S46 (2005). (Pubitemid 40460820)
10. Sulkanen, S. et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115, 1322-1328 (1998). (Pubitemid 28545980)
11. Scott, B. B., Goodall, A., Stephenson, P. & Jenkins, D. Small intestinal plasma cells in coeliac disease. Gut 25, 41-46 (1984). (Pubitemid 14125745)
12. Dorum, S. et al. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are peptide fragments harboring celiac disease T-cell epitopes. PLoS ONE 5, e14056 (2010).
13. Osman, A. A. et al. B cell epitopes of gliadin. Clin. Exp. Immunol. 121, 248-254 (2000). (Pubitemid 30659761)
14. Ballew, J. T. et al. Antibody biomarker discovery through in vitro directed evolution of consensus recognition epitopes. Proc. Natl Acad. Sci. USA 110, 19330-19335 (2013).
15. Aleanzi, M., Demonte, A. M., Esper, C., Garcilazo, S. & Waggener, M. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin. Chem. 47, 2023-2028 (2001). (Pubitemid 33010719)
16. Bjorck, S., Brundin, C., Lorinc, E., Lynch, K. F. & Agardh, D. Screening detects a high proportion of celiac disease in young HLA-genotyped children. J. Pediatr. Gastroenterol. Nutr. 50, 49-53 (2010).
17. Smith, K. et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4, 372-384 (2009).
18. Di Niro, R. et al. Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosa. J. Immunol. 185, 5377-5383 (2010).
19. Bateman, E. A. et al. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin. Gut 53, 1274-1278 (2004). (Pubitemid 39120111)
20. Schwertz, E. et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin. Chem. 50, 2370-2375 (2004). (Pubitemid 39552174)
21. Wang, M., Rada, C. & Neuberger, M. S. Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID. J. Exp. Med. 207, 141-153 (2010).
22. Goodnow, C. C., Vinuesa, C. G., Randall, K. L., Mackay, F. & Brink, R. Control systems and decision making for antibody production. Nat. Immunol. 11, 681-688 (2010).
23. Maizels, N. & Bothwell, A. The T-cell-independent immune response to the hapten NP uses a large repertoire of heavy chain genes. Cell 43, 715-720 (1985). (Pubitemid 16090709)
24. MacLennan, I. C. Germinal centers. Annu. Rev. Immunol. 12, 117-139 (1994). (Pubitemid 24140411)
25. Toellner, K. M. et al. Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J. Exp. Med. 195, 383-389 (2002).
26. MacLennan, I. C. et al. Extrafollicular antibody responses. Immunol. Rev. 194, 8-18 (2003). (Pubitemid 36886424)
27. Takahashi, Y., Dutta, P. R., Cerasoli, D. M. & Kelsoe, G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. J. Exp. Med. 187, 885-895 (1998). (Pubitemid 28141662)
28. Chan, T. D. et al. Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen. Immunity 37, 893-904 (2012).
29. Herlands, R. A., William, J., Hershberg, U. & Shlomchik, M. J. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur. J. Immunol. 37, 3339-3351 (2007).
30. Mäki, M. in: Proceedings of the Sixth International Symposium Coeliac Disease (eds Feighery, C. & O'Farrelly, C.) 246-252 (Oak Tree Press, 1992).
31. Sollid, L. M., Molberg, O., McAdam, S. & Lundin, K. E. Autoantibodies in coeliac disease: tissue transglutaminase - guilt by association? Gut 41, 851-852 (1997). (Pubitemid 28023192)
32. Sollid, L. M., Qiao, S. W., Anderson, R. P., Gianfrani, C. & Koning, F. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 64, 455-460 (2012).
33. Chappell, C. P., Draves, K. E., Giltiay, N. V. & Clark, E. A. Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses. J. Exp. Med. 209, 1825-1840 (2012).
34. Ho, F., Lortan, J. E., MacLennan, I. C. & Khan, M. Distinct short-lived and long-lived antibody-producing cell populations. Eur. J. Immunol. 16, 1297-1301 (1986). (Pubitemid 17171537)
35. Lee, S. K. et al. B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J. Exp. Med. 208, 1377-1388 (2011).
36. Kishi, Y., Aiba, Y., Higuchi, T., Furukawa, K., Tokuhisa, T., Takemori, T. & Tsubata, T. Augmented antibody response with premature germinal center regression in CD40L transgenic mice. J Immunol 185, 211-219 (2010).
37. Erickson, L. D. et al. Short-circuiting long-lived humoral immunity by the heightened engagement of CD40. J. Clin. Invest. 109, 613-620 (2002). (Pubitemid 34204840)
38. Yu, D. et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450, 299-303 (2007).
39. Kawamoto, S. et al. The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science 336, 485-489 (2012).
40. Pratama, A. & Vinuesa, C. G. Control of TFH cell numbers: why and how? Immunol. Cell. Biol. 92, 40-48 (2014).
41. Nilsen, E. M. et al. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37, 766-776 (1995).
42. Lee, S. K. et al. Interferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity 37, 880-892 (2012).
43. Shulman, Z. et al. T follicular helper cell dynamics in germinal centers. Science 341, 673-677 (2013).
44. Iversen, R. et al. Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J. Immunol. 190, 5981-5991 (2013).
45. Lingwood, D. et al. Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 489, 566-570 (2012).
46. Wu, X. et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333, 1593-1602 (2011).
47. Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193-1201 (2011).
48. Kagnoff, M. F. Two genetic loci control the murine immune response to A-gliadin, a wheat protein that activates coeliac sprue. Nature 296, 158-160 (1982). (Pubitemid 12160913)
49. Kagnoff, M. F. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 131, 1977-1980 (2006). (Pubitemid 44958522)
50. Roncoroni, L. et al. Isolation and culture of fibroblasts from endoscopic duodenal biopsies of celiac patients. J. Transl. Med. 7, 40 (2009).